Literature DB >> 883559

Dopamine in thelimbic regions of the human brain: normal and abnormal.

I J Farley, K S Price, O Hornykiewicz.   

Abstract

1. In the human brain, DA was found in appreciable amounts in most of the examined basal telencephalic limbic regions, with the nucleus accumbens having the highest mean level (3.38 microgram/g). In the cortical areas of the limbic lobe of Broca, DA could be measured with certainty only in the parolfactory gyrus (0.35 microgram/g). 2. In patients with Parkinson's disease, the DA concentration in the parolfactory gyrus and nucleur accumbens was markedly reduced, whereas little change was seen in the olfactory areas. Quantitatively, the DA decrease in the nucleus accumbens was of the same magnitude as in the caudate nucleus, being, in both regions, distinctly less severe than in the putamen. 3. In three cases of paranoid schizophrenia, there were no statistically significant changes of the mean levels of DA or HVA in the nucleus accumbens. However, the DA/HVA ratio was shifted noticeably in favor of HVA, possibly indicating an increase in DA turnover. This change was less pronounced in the putamen of these cases and was absent in the caudate nucleus. 4. The possibility of the substantia nigra contributing to the dopaminergic innervation of the human nucleus accumbens, as well as the significance of the observations on DA metabolism in the schizophrenic cases, is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 883559

Source DB:  PubMed          Journal:  Adv Biochem Psychopharmacol        ISSN: 0065-2229


  10 in total

1.  Dopamine receptors mediate strategy abandoning via modulation of a specific prelimbic cortex-nucleus accumbens pathway in mice.

Authors:  Qiaoling Cui; Qian Li; Hongyan Geng; Lei Chen; Nancy Y Ip; Ya Ke; Wing-Ho Yung
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

Review 2.  Deterioration of dopaminergic pathways and alterations in cognition and motor functions.

Authors:  B Dubois; B Pillon; Y Agid
Journal:  J Neurol       Date:  1992       Impact factor: 4.849

Review 3.  Rule-based category learning in patients with Parkinson's disease.

Authors:  Amanda Price; J Vincent Filoteo; W Todd Maddox
Journal:  Neuropsychologia       Date:  2009-02-02       Impact factor: 3.139

Review 4.  Reward processing in neurodegenerative disease.

Authors:  David C Perry; Joel H Kramer
Journal:  Neurocase       Date:  2014-01-13       Impact factor: 0.881

5.  Uncovering the role of the nucleus accumbens in schizophrenia: A postmortem analysis of tyrosine hydroxylase and vesicular glutamate transporters.

Authors:  Lesley A McCollum; Rosalinda C Roberts
Journal:  Schizophr Res       Date:  2015-09-18       Impact factor: 4.939

6.  Evaluation of olfactory function by topographic EEG analysis in patients with Parkinson's disease.

Authors:  S Gori; R Massetani; L Murri
Journal:  Ital J Neurol Sci       Date:  1995-12

7.  Reply: is nucleus accumbens atrophy correlated with cognitive symptoms of Parkinson's disease?

Authors:  Oury Monchi; Alexandru Hanganu
Journal:  Brain       Date:  2014-07-16       Impact factor: 13.501

8.  Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease.

Authors:  Nicolaas I Bohnen; Satyanarayana Gedela; Hiroto Kuwabara; Gregory M Constantine; Chester A Mathis; Stephanie A Studenski; Robert Y Moore
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

9.  Imaging Dopamine and Serotonin Systems on MPTP Monkeys: A Longitudinal PET Investigation of Compensatory Mechanisms.

Authors:  Benedicte Ballanger; Maude Beaudoin-Gobert; Sara Neumane; Justine Epinat; Elise Metereau; Sandra Duperrier; Emmanuel Broussolle; Stephane Thobois; Frederic Bonnefoi; Christian Tourvielle; Franck Lavenne; Nicolas Costes; Didier Lebars; Luc Zimmer; Véronique Sgambato-Faure; Léon Tremblay
Journal:  J Neurosci       Date:  2016-02-03       Impact factor: 6.167

Review 10.  Structural Neuroimaging Markers of Cognitive Decline in Parkinson's Disease.

Authors:  Alexandru Hanganu; Oury Monchi
Journal:  Parkinsons Dis       Date:  2016-04-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.